A Randomized Double-Blind Phase 4 Study to Evaluate

Project: Research project

Project Details

Description

A Randomized Double-Blind Phase 4 Study to Evaluate the Safety and Proportion of Subjects with Fistula Healing in 2 Dose Regimens of Entyvio (Vedolizumab IV) in the Treatment of Fistulizing Crohn's Disease (ENTERPRISE)
StatusFinished
Effective start/end date11/24/156/30/19

Funding

  • TAKEDA DEVELOPMENT CENTER AMERICAS, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.